Forums Forums - Off Topic Forum FUN

Go Back   Forums Forums - Off Topic Forum FUN > Off Topic Forums > Diabetes Peer Support Forum

Diabetes Peer Support Forum Talk of diabetes issues, questions and solutions.

Thread Tools Search this Thread Display Modes
Old 09-15-2017, 08:01 AM
Loudmouth's Avatar
Loudmouth Loudmouth is offline
Join Date: Aug 2016
Location: DIXIE
Posts: 50
Thanks: 32
Thanked 52 Times in 22 Posts
Loudmouth is on a distinguished road
Default New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabet

Research finds Sotagliflozin may be first drug to improve glucose control without weight gain or increase in severe hypoglycemia.

A University of Colorado Anschutz Medical Campus study finds Sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.

Principal results were published today in the New England Journal of Medicine. This drug is in phase 3 clinical trials. Among 1,402 trial participants given the drug, Sotagliflozin showed clinically meaningful and statistically significant effects on glucose control. A1C, was also significantly improved without severe hypoglycemia. Patients also had weight loss.

Sotagliflozin has the potential to become the first new treatment innovation in nearly a century since insulin.

Most patients do not achieve optimal glycemic control with insulin alone. A1C concentrations, hypertension and reduction in body weight are critical issues which significantly impact people living with type 1 diabetes.

"If approved by the FDA, Sotagliflozin may be the first oral drug that helps patients with type 1 diabetes in improving their glucose control without any weight gain increase and severe hypoglycemia," Garg said. "If long-term use continues to show similar metabolic improvements in patients with type 1 diabetes, it is likely that the long-term complications of diabetes would be significantly reduced."

Sotagliflozin would be used in conjunction with insulin. Trial participants taking the drug as an oral pill alongside traditional insulin treatments experienced significant improvements in glucose control, a drop in systolic and diastolic blood pressure and weight loss.

New England Journal of Medicine

Reply With Quote
Old 09-15-2017, 11:59 AM
Melensdad's Avatar
Melensdad Melensdad is offline
Jerk in a Hawaiian Shirt

Join Date: Sep 2005
Location: Indiana
Posts: 36,749
Thanks: 2,747
Thanked 11,238 Times in 4,425 Posts
Melensdad has a spectacular aura aboutMelensdad has a spectacular aura about
Default Re: New oral diabetes drug shows promise in phase 3 trial for patients with type 1 di

It would be very helpful if you could provide the actual links to these stories.

"We are fast approaching the stage of the ultimate inversion:
the stage where the government is free to do anything it pleases,
while the citizens may act only by permission; which is the stage
of the darkest periods of human history, the stage of rule by brute force."
- Ayn Rand
Reply With Quote

in clinical trials, reduces need for insulin, sotagliflozin, type 1 diabetes, uc study

Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Compounds in Cocoa May Help Delay and treat Type 2 Diabetes Loudmouth Diabetes Peer Support Forum 1 09-14-2017 12:25 PM
Type 1 diabetes patients retain some ability to produce insulin Loudmouth Diabetes Peer Support Forum 0 09-13-2017 09:15 AM
Type 1 Diabetes May Soon Meet Its Match Loudmouth Diabetes Peer Support Forum 3 09-12-2017 12:15 PM
A form of stem cell research shows promise loboloco Off Topic Debate Forum 3 07-26-2012 08:36 PM
Greece tells company to lower diabetes drug price, company stops selling drug instead Melensdad Open Forum 65 06-02-2010 05:44 PM

All times are GMT -4. The time now is 03:56 PM.

Powered by vBulletin® Version 3.8.9
Copyright ©2000 - 2020, vBulletin Solutions, Inc.
Copyright © 2002 - 2020